STATE STEM CELL AGENCY GRANTS WORKING GROUP AGENDA 9/1-3/10

Return to CIRM Meetings and Events

Stem Cell Agency Grants Working Group Meeting 

 

MEETING OF THE
SCIENTIFIC AND MEDICAL RESEARCH FUNDING WORKING GROUP
(GRANTS REVIEW WORKING GROUP)
OF THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)
Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

OPEN SESSION: Sept. 1st        8:30am – 9:00am
1. Call to Order
2. Roll Call
3. Welcome & Chair’s Comments
4. Public Comment

Members of the public will be invited to provide testimony. Speakers are asked to limit their testimony to three (3) minutes.

CLOSED SESSION:
5. Evaluation of RFA 10-01 Applications      Sept. 1st      9:00am – 6:00pm (est.)
6. Evaluation of RFA 10-01 Applications      Sept. 2nd     8:30am – 6:00pm (est.)
7. Evaluation of RFA 10-01 Applications      Sept. 3rd      9:00am – 1:00pm (est.)
8. Adjournment

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Meybel Cortez at the California Institute for Regenerative Medicine at 415-396-9132 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific & Medical Research Funding Working Group meeting may be referred to Dr. Gil Sambrano at the California Institute for Regenerative Medicine at gsambrano@cirm.ca.gov or 415-396-9103.

 

 

 

---